SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 149 filers reported holding SERES THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $814 | -35.2% | 342,200 | +30.4% | 0.02% | -33.3% |
| Q2 2023 | $1,257 | -15.5% | 262,325 | 0.0% | 0.03% | -17.5% |
| Q1 2023 | $1,487 | +0.2% | 262,325 | -1.0% | 0.04% | -4.8% |
| Q4 2022 | $1,484 | -99.9% | 265,000 | +33.2% | 0.04% | +10.5% |
| Q3 2022 | $1,278,000 | +87.1% | 199,000 | 0.0% | 0.04% | +81.0% |
| Q2 2022 | $683,000 | +53.5% | 199,000 | +218.7% | 0.02% | +75.0% |
| Q1 2022 | $445,000 | -14.4% | 62,450 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $520,000 | +19.5% | 62,450 | 0.0% | 0.01% | +9.1% |
| Q3 2021 | $435,000 | -70.8% | 62,450 | 0.0% | 0.01% | -70.3% |
| Q2 2021 | $1,489,000 | – | 62,450 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $110,730,646 | 4.94% |
| Lion Point Capital, LP | 691,803 | $3,313,736 | 1.50% |
| Eversept Partners, LP | 3,076,756 | $14,737,661 | 1.23% |
| Soleus Capital Management, L.P. | 2,045,983 | $9,800,259 | 1.09% |
| Knott David M Jr | 470,000 | $2,251 | 0.90% |
| GREAT POINT PARTNERS LLC | 938,067 | $4,493,341 | 0.88% |
| Simplify Asset Management Inc. | 550,626 | $2,637,499 | 0.35% |
| Delphia (USA) Inc. | 33,913 | $162,443 | 0.26% |
| Alpha DNA Investment Management LLC | 138,536 | $663,587 | 0.22% |
| Avoro Capital Advisors LLC | 2,500,000 | $11,975,000 | 0.16% |